Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Revenue by Segment

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	437.93B	417.49B	409.73B	485.07B	381.08B
Pharmaceuticals Growth	4.90%	1.89%	-15.53%	27.29%	-3.70%
Total	437.93B	417.49B	409.73B	485.07B	381.08B
Total Growth	4.90%	1.89%	-15.53%	27.29%	-3.70%

Revenue by Geography

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Vietnam	437.93B	417.49B	409.73B	485.07B	381.08B
Vietnam Growth	4.90%	1.89%	-15.53%	27.29%	-3.70%
Total	437.93B	417.49B	409.73B	485.07B	381.08B
Total Growth	4.90%	1.89%	-15.53%	27.29%	-3.70%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error